Report Detail

Request for Sample of this report

Pharma & Healthcare Global Medical Nuclide Products Market 2026 by Company, Regions, Type and Application, Forecast to 2032

  • RnM4733032
    • |
  • 24 August, 2026
    • |
  • Global
    • |
  • 132 Pages
    • |
  • GIR
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Medical Nuclide Products market size was valued at US$ 11470 million in 2025 and is forecast to a readjusted size of US$ 20850 million by 2032 with a CAGR of 9.0% during review period.
Medical nuclide products refer to medical preparations or devices containing radioactive isotopes, which achieve diagnostic or therapeutic functions through the radiation released by their decay. Such products must strictly comply with radioactive safety standards and are widely used in the field of nuclear medicine. For example, imaging agents used in diagnosis assist in disease detection through gamma-ray imaging, and iodine-131 and lutetium-177 used in treatment destroy diseased tissues through targeted radiation. Their production, quality control and clinical use are subject to the dual constraints of national nuclear safety regulations and the drug regulatory system to ensure patient safety and the effectiveness of diagnosis and treatment.
The global medical nuclide products market is being driven by the growing prevalence of chronic diseases such as cancer, cardiovascular disorders, and neurodegenerative conditions, which require precise diagnostic imaging and targeted radiopharmaceutical therapies. Technological advancements in nuclear imaging modalities like PET and SPECT, combined with the increasing adoption of theranostic approaches, have significantly expanded clinical applications for medical nuclides. In addition, favorable government initiatives to promote nuclear medicine infrastructure, and increasing investment in radioisotope production facilities, particularly in developing regions, are further accelerating market growth.
Despite its potential, the medical nuclide products market faces several challenges. The short half-life of many radioisotopes requires localized and timely production, which puts pressure on logistics and supply chain networks, especially in geographically dispersed regions. Regulatory complexities surrounding the handling, transport, and storage of radioactive materials also increase operational burden. Moreover, a global shortage of key isotopes like Mo-99, and limited access to cyclotrons and nuclear reactors in many countries, hampers consistent supply. High costs and the scarcity of trained nuclear medicine professionals further constrain market expansion in certain areas.
This report is a detailed and comprehensive analysis for global Medical Nuclide Products market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Medical Nuclide Products market size and forecasts, in consumption value ($ Million), 2021-2032
Global Medical Nuclide Products market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Medical Nuclide Products market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Medical Nuclide Products market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Medical Nuclide Products
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Medical Nuclide Products market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Cardinal Health, GE Healthcare, Lantheus Medical Imaging, Bayer, Eli Lilly, Bracco Imaging, Curium Pharma, Jubilant Pharmova, Aurobindo Pharma, Novartis, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Medical Nuclide Products market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Technetium-99m
Fluorine-18
Gallium-68
Iodine-123
Indium-111
Copper-64
Xenon-133
Iodine-131
Yttrium-90
Lutetium-177
Strontium-89
Samarium-153
Radium-223
Iodine-125
Other
Market segment by Product
Therapeutic Nuclear Medicine
Diagnostic Nuclear Medicine
Market segment by Application
Cancer
Cardiovascular Disease
Bone and Joint Disease
Other
Market segment by players, this report covers
Cardinal Health
GE Healthcare
Lantheus Medical Imaging
Bayer
Eli Lilly
Bracco Imaging
Curium Pharma
Jubilant Pharmova
Aurobindo Pharma
Novartis
Siemens
NTP Radioisotopes
ANSTO
Polatom
China Isotope & Radiation
Yantai Dongcheng Pharmaceutical
Saide Biotechnology
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Medical Nuclide Products product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Medical Nuclide Products, with revenue, gross margin, and global market share of Medical Nuclide Products from 2021 to 2026.
Chapter 3, the Medical Nuclide Products competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Medical Nuclide Products market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Medical Nuclide Products.
Chapter 13, to describe Medical Nuclide Products research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Medical Nuclide Products by Type
    • 1.3.1 Overview: Global Medical Nuclide Products Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Medical Nuclide Products Consumption Value Market Share by Type in 2025
    • 1.3.3 Technetium-99m
    • 1.3.4 Fluorine-18
    • 1.3.5 Gallium-68
    • 1.3.6 Iodine-123
    • 1.3.7 Indium-111
    • 1.3.8 Copper-64
    • 1.3.9 Xenon-133
    • 1.3.10 Iodine-131
    • 1.3.11 Yttrium-90
  • 1.4 Classification of Medical Nuclide Products by Product
    • 1.4.1 Overview: Global Medical Nuclide Products Market Size by Product: 2021 Versus 2025 Versus 2032
    • 1.4.2 Global Medical Nuclide Products Consumption Value Market Share by Product in 2025
    • 1.4.3 Therapeutic Nuclear Medicine
    • 1.4.4 Diagnostic Nuclear Medicine
  • 1.5 Global Medical Nuclide Products Market by Application
    • 1.5.1 Overview: Global Medical Nuclide Products Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.5.2 Cancer
    • 1.5.3 Cardiovascular Disease
    • 1.5.4 Bone and Joint Disease
    • 1.5.5 Other
  • 1.6 Global Medical Nuclide Products Market Size & Forecast
  • 1.7 Global Medical Nuclide Products Market Size and Forecast by Region
    • 1.7.1 Global Medical Nuclide Products Market Size by Region: 2021 VS 2025 VS 2032
    • 1.7.2 Global Medical Nuclide Products Market Size by Region, (2021-2032)
    • 1.7.3 North America Medical Nuclide Products Market Size and Prospect (2021-2032)
    • 1.7.4 Europe Medical Nuclide Products Market Size and Prospect (2021-2032)
    • 1.7.5 Asia-Pacific Medical Nuclide Products Market Size and Prospect (2021-2032)
    • 1.7.6 South America Medical Nuclide Products Market Size and Prospect (2021-2032)
    • 1.7.7 Middle East & Africa Medical Nuclide Products Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Cardinal Health
    • 2.1.1 Cardinal Health Details
    • 2.1.2 Cardinal Health Major Business
    • 2.1.3 Cardinal Health Medical Nuclide Products Product and Solutions
    • 2.1.4 Cardinal Health Medical Nuclide Products Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Cardinal Health Recent Developments and Future Plans
  • 2.2 GE Healthcare
    • 2.2.1 GE Healthcare Details
    • 2.2.2 GE Healthcare Major Business
    • 2.2.3 GE Healthcare Medical Nuclide Products Product and Solutions
    • 2.2.4 GE Healthcare Medical Nuclide Products Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 GE Healthcare Recent Developments and Future Plans
  • 2.3 Lantheus Medical Imaging
    • 2.3.1 Lantheus Medical Imaging Details
    • 2.3.2 Lantheus Medical Imaging Major Business
    • 2.3.3 Lantheus Medical Imaging Medical Nuclide Products Product and Solutions
    • 2.3.4 Lantheus Medical Imaging Medical Nuclide Products Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Lantheus Medical Imaging Recent Developments and Future Plans
  • 2.4 Bayer
    • 2.4.1 Bayer Details
    • 2.4.2 Bayer Major Business
    • 2.4.3 Bayer Medical Nuclide Products Product and Solutions
    • 2.4.4 Bayer Medical Nuclide Products Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Bayer Recent Developments and Future Plans
  • 2.5 Eli Lilly
    • 2.5.1 Eli Lilly Details
    • 2.5.2 Eli Lilly Major Business
    • 2.5.3 Eli Lilly Medical Nuclide Products Product and Solutions
    • 2.5.4 Eli Lilly Medical Nuclide Products Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Eli Lilly Recent Developments and Future Plans
  • 2.6 Bracco Imaging
    • 2.6.1 Bracco Imaging Details
    • 2.6.2 Bracco Imaging Major Business
    • 2.6.3 Bracco Imaging Medical Nuclide Products Product and Solutions
    • 2.6.4 Bracco Imaging Medical Nuclide Products Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Bracco Imaging Recent Developments and Future Plans
  • 2.7 Curium Pharma
    • 2.7.1 Curium Pharma Details
    • 2.7.2 Curium Pharma Major Business
    • 2.7.3 Curium Pharma Medical Nuclide Products Product and Solutions
    • 2.7.4 Curium Pharma Medical Nuclide Products Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Curium Pharma Recent Developments and Future Plans
  • 2.8 Jubilant Pharmova
    • 2.8.1 Jubilant Pharmova Details
    • 2.8.2 Jubilant Pharmova Major Business
    • 2.8.3 Jubilant Pharmova Medical Nuclide Products Product and Solutions
    • 2.8.4 Jubilant Pharmova Medical Nuclide Products Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Jubilant Pharmova Recent Developments and Future Plans
  • 2.9 Aurobindo Pharma
    • 2.9.1 Aurobindo Pharma Details
    • 2.9.2 Aurobindo Pharma Major Business
    • 2.9.3 Aurobindo Pharma Medical Nuclide Products Product and Solutions
    • 2.9.4 Aurobindo Pharma Medical Nuclide Products Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Aurobindo Pharma Recent Developments and Future Plans
  • 2.10 Novartis
    • 2.10.1 Novartis Details
    • 2.10.2 Novartis Major Business
    • 2.10.3 Novartis Medical Nuclide Products Product and Solutions
    • 2.10.4 Novartis Medical Nuclide Products Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Novartis Recent Developments and Future Plans
  • 2.11 Siemens
    • 2.11.1 Siemens Details
    • 2.11.2 Siemens Major Business
    • 2.11.3 Siemens Medical Nuclide Products Product and Solutions
    • 2.11.4 Siemens Medical Nuclide Products Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Siemens Recent Developments and Future Plans
  • 2.12 NTP Radioisotopes
    • 2.12.1 NTP Radioisotopes Details
    • 2.12.2 NTP Radioisotopes Major Business
    • 2.12.3 NTP Radioisotopes Medical Nuclide Products Product and Solutions
    • 2.12.4 NTP Radioisotopes Medical Nuclide Products Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 NTP Radioisotopes Recent Developments and Future Plans
  • 2.13 ANSTO
    • 2.13.1 ANSTO Details
    • 2.13.2 ANSTO Major Business
    • 2.13.3 ANSTO Medical Nuclide Products Product and Solutions
    • 2.13.4 ANSTO Medical Nuclide Products Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 ANSTO Recent Developments and Future Plans
  • 2.14 Polatom
    • 2.14.1 Polatom Details
    • 2.14.2 Polatom Major Business
    • 2.14.3 Polatom Medical Nuclide Products Product and Solutions
    • 2.14.4 Polatom Medical Nuclide Products Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Polatom Recent Developments and Future Plans
  • 2.15 China Isotope & Radiation
    • 2.15.1 China Isotope & Radiation Details
    • 2.15.2 China Isotope & Radiation Major Business
    • 2.15.3 China Isotope & Radiation Medical Nuclide Products Product and Solutions
    • 2.15.4 China Isotope & Radiation Medical Nuclide Products Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 China Isotope & Radiation Recent Developments and Future Plans
  • 2.16 Yantai Dongcheng Pharmaceutical
    • 2.16.1 Yantai Dongcheng Pharmaceutical Details
    • 2.16.2 Yantai Dongcheng Pharmaceutical Major Business
    • 2.16.3 Yantai Dongcheng Pharmaceutical Medical Nuclide Products Product and Solutions
    • 2.16.4 Yantai Dongcheng Pharmaceutical Medical Nuclide Products Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 Yantai Dongcheng Pharmaceutical Recent Developments and Future Plans
  • 2.17 Saide Biotechnology
    • 2.17.1 Saide Biotechnology Details
    • 2.17.2 Saide Biotechnology Major Business
    • 2.17.3 Saide Biotechnology Medical Nuclide Products Product and Solutions
    • 2.17.4 Saide Biotechnology Medical Nuclide Products Revenue, Gross Margin and Market Share (2021-2026)
    • 2.17.5 Saide Biotechnology Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Medical Nuclide Products Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Medical Nuclide Products by Company Revenue
    • 3.2.2 Top 3 Medical Nuclide Products Players Market Share in 2025
    • 3.2.3 Top 6 Medical Nuclide Products Players Market Share in 2025
  • 3.3 Medical Nuclide Products Market: Overall Company Footprint Analysis
    • 3.3.1 Medical Nuclide Products Market: Region Footprint
    • 3.3.2 Medical Nuclide Products Market: Company Product Type Footprint
    • 3.3.3 Medical Nuclide Products Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Medical Nuclide Products Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Medical Nuclide Products Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Medical Nuclide Products Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Medical Nuclide Products Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Medical Nuclide Products Consumption Value by Type (2021-2032)
  • 6.2 North America Medical Nuclide Products Market Size by Application (2021-2032)
  • 6.3 North America Medical Nuclide Products Market Size by Country
    • 6.3.1 North America Medical Nuclide Products Consumption Value by Country (2021-2032)
    • 6.3.2 United States Medical Nuclide Products Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Medical Nuclide Products Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Medical Nuclide Products Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Medical Nuclide Products Consumption Value by Type (2021-2032)
  • 7.2 Europe Medical Nuclide Products Consumption Value by Application (2021-2032)
  • 7.3 Europe Medical Nuclide Products Market Size by Country
    • 7.3.1 Europe Medical Nuclide Products Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Medical Nuclide Products Market Size and Forecast (2021-2032)
    • 7.3.3 France Medical Nuclide Products Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Medical Nuclide Products Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Medical Nuclide Products Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Medical Nuclide Products Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Medical Nuclide Products Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Medical Nuclide Products Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Medical Nuclide Products Market Size by Region
    • 8.3.1 Asia-Pacific Medical Nuclide Products Consumption Value by Region (2021-2032)
    • 8.3.2 China Medical Nuclide Products Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Medical Nuclide Products Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Medical Nuclide Products Market Size and Forecast (2021-2032)
    • 8.3.5 India Medical Nuclide Products Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Medical Nuclide Products Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Medical Nuclide Products Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Medical Nuclide Products Consumption Value by Type (2021-2032)
  • 9.2 South America Medical Nuclide Products Consumption Value by Application (2021-2032)
  • 9.3 South America Medical Nuclide Products Market Size by Country
    • 9.3.1 South America Medical Nuclide Products Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Medical Nuclide Products Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Medical Nuclide Products Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Medical Nuclide Products Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Medical Nuclide Products Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Medical Nuclide Products Market Size by Country
    • 10.3.1 Middle East & Africa Medical Nuclide Products Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Medical Nuclide Products Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Medical Nuclide Products Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Medical Nuclide Products Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Medical Nuclide Products Market Drivers
  • 11.2 Medical Nuclide Products Market Restraints
  • 11.3 Medical Nuclide Products Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Medical Nuclide Products Industry Chain
  • 12.2 Medical Nuclide Products Upstream Analysis
  • 12.3 Medical Nuclide Products Midstream Analysis
  • 12.4 Medical Nuclide Products Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Medical Nuclide Products. Industry analysis & Market Report on Medical Nuclide Products is a syndicated market report, published as Global Medical Nuclide Products Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Medical Nuclide Products market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo